CSNK1A1L: A Potential Drug Target and Biomarker for Cancer (G122011)

Target Name: CSNK1A1L

NCBI ID: G122011

CSNK1A1L

CSNK1A1L: A Potential Drug Target and Biomarker for Cancer

Cancer is one of the leading causes of human morbidity and mortality, affecting millions of people worldwide. The development of new treatments and biomarkers for cancer has become a major focus in the field of cancer research. One potential drug target and biomarker that has gained significant attention in recent years is CSNK1A1L, a gene that has been identified as a potential drug target and biomarker for cancer. In this article, we will explore the biology of CSNK1A1L, its potential as a drug target and biomarker, and the current research being conducted to investigate its utility in cancer treatment.

The CSNK1A1L gene

CSNK1A1L is a gene that encodes a protein known as CSNK1A1L, a protein that is involved in a variety of cellular processes. The CSNK1A1L gene was identified in the late 1990s as a potential gene that could be targeted by drugs to inhibit its function in cell signaling pathways. Specifically, studies have shown that CSNK1A1L is involved in the regulation of cell adhesion, a process that is critical for the development and progression of many types of cancer.

In addition to its role in cell signaling pathways, CSNK1A1L has also been shown to play a role in the regulation of cell survival. Studies have shown that CSNK1A1L plays a role in the regulation of cell apoptosis, a process that is regulated by a variety of factors including the expression of genes involved in cell signaling pathways. Additionally, CSNK1A1L has been shown to be involved in the regulation of cell proliferation, a process that is critical for the growth and survival of cancer cells.

The potential drug target and biomarker properties of CSNK1A1L

The potential drug target and biomarker properties of CSNK1A1L make it an attractive target for cancer treatment. By inhibiting the function of CSNK1A1L, researchers hope to disrupt the signaling pathways that are involved in cancer cell growth, proliferation, and survival. This, in turn, could lead to the inhibition of the growth and spread of cancer cells, an important step in the development of new cancer treatments.

One of the key advantages of targeting CSNK1A1L is that it is a gene that is expressed in a wide variety of tissues and cells, making it an attractive target for drug development. Additionally, studies have shown that CSNK1A1L is involved in a variety of cellular processes that are involved in cancer development, making it a potential biomarker for cancer diagnosis and treatment.

Current research on CSNK1A1L

Current research on CSNK1A1L is focused on its potential as a drug target and biomarker for cancer. One of the main areas of research is the study of its function in cancer signaling pathways. Studies have shown that CSNK1A1L is involved in the regulation of cell adhesion, cell apoptosis, and cell proliferation, all of which are critical processes involved in cancer development.

Another area of research is the study of CSNK1A1L as a potential biomarker for cancer diagnosis and treatment. Studies have shown that CSNK1A1L is expressed in a variety of tissues and cells, making it an attractive target for diagnostic tests and cancer treatments. Additionally, the regulation of CSNK1A1L has been shown to be involved in the development of various types of cancer, making it a potential biomarker for cancer diagnosis and treatment.

The potential implications of CSNK1A1L as a drug target and biomarker for cancer are significant. Targeting CSNK1A1L with drugs that inhibit its function could lead to the inhibition of the signaling pathways that are involved in cancer cell growth, proliferation, and survival, leading to the inhibition of the growth and spread of cancer cells. Additionally, the regulation of CSNK1A1L has been shown to be involved in the development of various types of cancer, making it

Protein Name: Casein Kinase 1 Alpha 1 Like

Functions: Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling (By similarity)

The "CSNK1A1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSNK1A1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets